• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Int Med Res . Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19

tetano

Editor, Senior Moderator
J Int Med Res


. 2021 Jul;49(7):3000605211030124.
doi: 10.1177/03000605211030124.
Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19


Shaimaa Hani Fouad[SUP] 1 [/SUP], Mohamed Farouk Allam[SUP] 2 [/SUP], Sara Ibrahim Taha[SUP] 3 [/SUP], Ahmed Ashraf Okba[SUP] 4 [/SUP], Amr Hosny[SUP] 5 [/SUP], Mayada Moneer[SUP] 1 [/SUP], Sylvia Wefky Roman[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions.
Aim: To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity.
Methods: In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020.
Results: The proportions of patients with mild, moderate, and severe COVID-19 differed significantly in association with hemoglobin levels, neutrophil counts, lymphocyte counts, NLR, and total leukocyte counts. Patients with severe COVID-19 had significantly lower hemoglobin levels than those with moderate or mild COVID-19. There were statistically significant negative associations between hemoglobin and D-dimer, age, and creatinine. The optimal hemoglobin cut-off value for prediction of disease severity was 11.6 g/dL. Using this cut-off value, hemoglobin had higher negative predictive value and sensitivity than NLR (92.4% and 51.3%, respectively). The specificity of hemoglobin as a prognostic marker was 79.3%.
Conclusion: Both NLR and hemoglobin level are of prognostic value for predicting severity of COVID-19. However, hemoglobin level displayed higher sensitivity than NLR. Hemoglobin level should be assessed upon admission in all patients and closely monitored throughout the disease course.

Keywords: Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity.
 
Back
Top Bottom